Sildenafil use and increased risk of incident melanoma in US men: a prospective cohort study
about
Let's rethinking about the safety of phosphodiesterase type 5 inhibitor in the patients with erectile dysfunction after radical prostatectomyThe new horizons of pharmacotherapy. Unexpected pharmacological actions and a new therapeutic strategy of phosphodiesterase-5 inhibitorsStimulation of soluble guanylyl cyclase protects against obesity by recruiting brown adipose tissuePDE5 inhibitors as therapeutics for heart disease, diabetes and cancerPhosphodiesterase Type 5 Inhibitors and Risk of Malignant Melanoma: Matched Cohort Study Using Primary Care Data from the UK Clinical Practice Research Datalink.Use of sildenafil or other phosphodiesterase inhibitors and risk of melanoma.Type 5 phosphodiesterase regulates glioblastoma multiforme aggressiveness and clinical outcome.Microphthalmia-associated transcription factor in melanoma development and MAP-kinase pathway targeted therapy.Relation of phosphodiesterase type 5 inhibitors and malignant melanoma: a meta-analysis and systematic review.The safety of phosphodiesterase type 5 inhibitors for erectile dysfunction.Pharmacodynamics, pharmacokinetics and clinical efficacy of phosphodiesterase-5 inhibitors.Targeting invasive properties of melanoma cells.Phosphodiesterase Type 5 Inhibitor Use and Disease Recurrence After Prostate Cancer Treatment.The Association between Phosphodiesterase Type 5 Inhibitors and Prostate Cancer: Results from the REDUCE StudyTadalafil has biologic activity in human melanoma. Results of a pilot trial with Tadalafil in patients with metastatic Melanoma (TaMe)Penile rehabilitation and cancer spreadMeta-Analysis of the Association Between Phosphodiesterase Inhibitors (PDE5Is) and Risk of Melanoma.Potential synergistic effect of phosphodiesterase inhibitors with chemotherapy in lung cancer.Viagra releases the brakes on melanoma growth.Phosphodiesterase type 5 and cancers: progress and challenges.Use of phosphodiesterase type 5 inhibitors and risk of melanoma: a meta-analysis of observational studies.Are phosphodiesterase type 5 inhibitors associated with increased risk of melanoma?: A systematic review and meta-analysis.Editorial: When Is Correlation Causation?Skin cancer associated with commonly prescribed drugs: tumor necrosis factor alpha inhibitors (TNF-αIs), angiotensin-receptor blockers (ARBs), phosphodiesterase type 5 inhibitors (PDE5Is) and statins -weighing the evidence.Phosphodiesterase Type 5 Inhibitor Use Following Radical Prostatectomy is not Associated with an Increased Risk of Biochemical Recurrence.cGMP Signaling and Vascular Smooth Muscle Cell Plasticity.How sildenafil (Viagra® ) may cause melanoma: a histopathologic study providing a potential physiological/etiopathological mechanism.Repurposing drugs in oncology (ReDO)-selective PDE5 inhibitors as anti-cancer agents.
P2860
Q26740135-F36BBCA8-5828-4ED7-87D1-56625EF83023Q27025700-20D17B31-6830-4834-AF8B-6F0D11007F2BQ30316523-9F27D506-57A0-40C4-8164-50DD29666218Q35827798-B215890E-7195-416C-835F-8D14459A6B5EQ36051506-1189331E-34A6-4422-9168-4D98FA3EC6FBQ37303804-3DD8AAFD-4AFD-40F9-9A3E-87D1DB592981Q37706584-4E691377-35E0-4ACD-ACDB-FF41A714F51DQ38394400-A2CEF411-0264-4195-84E8-4C7A163E9643Q38682645-BBE0C20A-159A-47BD-B027-2FF31CC7E016Q38692296-B6645CA3-7917-4092-AC54-39F56EEFE7F6Q38815890-106593EB-0EF0-401A-84CD-861575CA113EQ39135139-A3A04176-ABB3-40CE-92C4-B4AA4A777217Q40131482-11AD6E8D-9D70-45BB-B574-B89B7268862DQ41036693-C275B570-7BB2-4310-9C8E-ADE52AFA8685Q41067892-57E81534-5E97-4E85-A0B0-B1F414D89F5FQ41421138-44984A1B-897B-4C73-89E3-5235BA4F6ED4Q43063062-BE7B8B69-1988-4C37-ABEA-D52DF34DEE55Q47138288-52C78C8B-356C-45AD-A386-A87A26C331BAQ47144678-C87A6B89-8AD5-4E31-83E2-DC3C07F400CFQ47171803-9CFE1301-83C8-4C85-997E-62267967CDECQ49298466-D8347815-03E5-4581-A16E-E985B3F17E55Q49413924-708D1BE3-3BB7-4D6B-8D60-E36873D1045FQ50105546-B10081C9-F297-4C0C-9BF0-4AF8CF451211Q50155389-84075CD3-3EF1-43EF-A4B2-50F0DEA4D85CQ50896885-FA82599E-E147-4311-B366-FE4984DC6CB9Q52578398-07B7C482-E6FE-42AD-A342-F42CD615D112Q52763677-42399BBD-06C5-4035-95B6-40C7113B243AQ55247585-352F1502-B544-4A9D-9BDF-E294831C9048
P2860
Sildenafil use and increased risk of incident melanoma in US men: a prospective cohort study
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Sildenafil use and increased r ...... en: a prospective cohort study
@ast
Sildenafil use and increased r ...... en: a prospective cohort study
@en
Sildenafil use and increased r ...... en: a prospective cohort study
@nl
type
label
Sildenafil use and increased r ...... en: a prospective cohort study
@ast
Sildenafil use and increased r ...... en: a prospective cohort study
@en
Sildenafil use and increased r ...... en: a prospective cohort study
@nl
prefLabel
Sildenafil use and increased r ...... en: a prospective cohort study
@ast
Sildenafil use and increased r ...... en: a prospective cohort study
@en
Sildenafil use and increased r ...... en: a prospective cohort study
@nl
P2093
P2860
P1476
Sildenafil use and increased r ...... en: a prospective cohort study
@en
P2093
Abrar A Qureshi
Kathleen C Robinson
Wen-Qing Li
P2860
P304
P356
10.1001/JAMAINTERNMED.2014.594
P577
2014-06-01T00:00:00Z